DNTH
Price
$18.88
Change
+$0.31 (+1.67%)
Updated
Jun 6, 04:16 PM (EDT)
Capitalization
595.6M
IMNM
Price
$8.99
Change
-$0.13 (-1.43%)
Updated
Jun 6, 04:25 PM (EDT)
Capitalization
793.99M
68 days until earnings call
Interact to see
Advertisement

DNTH vs IMNM

Header iconDNTH vs IMNM Comparison
Open Charts DNTH vs IMNMBanner chart's image
Dianthus Therapeutics
Price$18.88
Change+$0.31 (+1.67%)
Volume$100
Capitalization595.6M
Immunome
Price$8.99
Change-$0.13 (-1.43%)
Volume$535
Capitalization793.99M
DNTH vs IMNM Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. IMNM commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a StrongBuy and IMNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (DNTH: $18.52 vs. IMNM: $9.13)
Brand notoriety: DNTH and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 50% vs. IMNM: 55%
Market capitalization -- DNTH: $595.6M vs. IMNM: $793.99M
DNTH [@Biotechnology] is valued at $595.6M. IMNM’s [@Biotechnology] market capitalization is $793.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNTH and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 7 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 6 bearish.
  • IMNM’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а +3.75% price change this week, while IMNM (@Biotechnology) price change was +1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

DNTH is expected to report earnings on Mar 11, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($794M) has a higher market cap than DNTH($596M). IMNM YTD gains are higher at: -14.077 vs. DNTH (-15.046). DNTH has higher annual earnings (EBITDA): -101.45M vs. IMNM (-109.95M). DNTH has more cash in the bank: 275M vs. IMNM (240M). DNTH has less debt than IMNM: DNTH (1.49M) vs IMNM (2.72M). IMNM has higher revenues than DNTH: IMNM (10.1M) vs DNTH (6.24M).
DNTHIMNMDNTH / IMNM
Capitalization596M794M75%
EBITDA-101.45M-109.95M92%
Gain YTD-15.046-14.077107%
P/E Ratio3.24N/A-
Revenue6.24M10.1M62%
Total Cash275M240M115%
Total Debt1.49M2.72M55%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHIMNM
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend about 1 month ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMNSX64.34N/A
N/A
ClearBridge Small Cap I
TGADX28.92N/A
N/A
Templeton Growth Adv
GGEAX22.55N/A
N/A
Nationwide Global Sust Eq A
RDWGX11.94N/A
N/A
American Funds Dvlpg Wld Gr&Inc R6
NRFAX12.58-0.01
-0.08%
Natixis AEW Global Focused Real Estate A

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+3.12%
IMNM - DNTH
48%
Loosely correlated
+1.16%
ERAS - DNTH
48%
Loosely correlated
+2.61%
CRNX - DNTH
46%
Loosely correlated
+0.59%
LRMR - DNTH
46%
Loosely correlated
+0.41%
XNCR - DNTH
46%
Loosely correlated
+0.22%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+1.16%
IDYA - IMNM
60%
Loosely correlated
-0.09%
BEAM - IMNM
55%
Loosely correlated
-0.87%
RXRX - IMNM
55%
Loosely correlated
-7.13%
SYRE - IMNM
54%
Loosely correlated
+0.54%
TRDA - IMNM
52%
Loosely correlated
+2.14%
More